“Advancing Education on Biosimilars”: Game Changer or More of the Same?

May 26, 2021

Generic Competition for Withdrawn Drug Products

March 25, 2021

Generic Competition for Withdrawn Drug Products

March 25, 2021

I’ve Been Sued for Patent Infringement… Is an IPR Worthwhile?

February 4, 2021

I’ve Been Sued for Patent Infringement… Is an IPR Worthwhile?

February 4, 2021

H.R. 4712: A “Narrowly Tailored” Obligation Under the Orphan Drug Act

November 20, 2020

Pre-Election Drug Pricing Regulation Efforts: Where Does Congress Stand?

September 30, 2020

Orphan Drug Exclusivity for CRISPR/Cas-Based Therapeutics

September 28, 2020